BG107002A - Птеридинови съединения за лечение на псориазис - Google Patents

Птеридинови съединения за лечение на псориазис Download PDF

Info

Publication number: BG107002A
Authority: BG; Bulgaria
Prior art keywords: thio; amino; pteridinone; group; methyl
Prior art date: 2000-02-23

Application number

BG107002A

Other languages

Bulgarian (bg)

English (en)

Inventor

Roger Bonnert

Stewart Gardiner

Fraser Hunt

Iain Walters

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-23

Filing date

2002-08-14

Publication date

2003-04-30

2002-08-14 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-04-30 Publication of BG107002A publication Critical patent/BG107002A/bg

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Addiction (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

BG107002A 2000-02-23 2002-08-14 Птеридинови съединения за лечение на псориазис BG107002A (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0004128A GB2359551A (en)	2000-02-23	2000-02-23	Pharmaceutically active pyrimidine derivatives
PCT/SE2001/000374 WO2001062758A1 (en)	2000-02-23	2001-02-20	Pteridine compounds for the treatment of psoriasis

Publications (1)

Publication Number	Publication Date
BG107002A true BG107002A (bg)	2003-04-30

Family

ID=9886153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG107002A BG107002A (bg)	2000-02-23	2002-08-14	Птеридинови съединения за лечение на псориазис

Country Status (33)

Country	Link
US (2)	US6875868B2 (pt)
EP (1)	EP1259512B1 (pt)
JP (1)	JP2003524012A (pt)
KR (1)	KR100795758B1 (pt)
CN (1)	CN1190437C (pt)
AR (1)	AR029805A1 (pt)
AT (1)	ATE250605T1 (pt)
AU (1)	AU782509B2 (pt)
BG (1)	BG107002A (pt)
BR (1)	BR0108600A (pt)
CA (1)	CA2400217C (pt)
CO (1)	CO5290258A1 (pt)
CZ (1)	CZ20022839A3 (pt)
DE (1)	DE60100851T2 (pt)
DK (1)	DK1259512T3 (pt)
EE (1)	EE200200461A (pt)
ES (1)	ES2206402T3 (pt)
GB (1)	GB2359551A (pt)
HK (1)	HK1050899A1 (pt)
HU (1)	HUP0204399A3 (pt)
IL (2)	IL151132A0 (pt)
IS (1)	IS6491A (pt)
MX (1)	MXPA02008233A (pt)
NO (1)	NO329898B1 (pt)
NZ (1)	NZ520355A (pt)
PL (1)	PL358004A1 (pt)
PT (1)	PT1259512E (pt)
RU (1)	RU2002125451A (pt)
SK (1)	SK12152002A3 (pt)
TR (1)	TR200302214T4 (pt)
UA (1)	UA72590C2 (pt)
WO (1)	WO2001062758A1 (pt)
ZA (1)	ZA200206590B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9903544D0 (sv) *	1999-10-01	1999-10-01	Astra Pharma Prod	Novel compounds
GB2359078A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB2359081A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active thiazolopyrimidines
GB2359551A (en) *	2000-02-23	2001-08-29	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
SE0003828D0 (sv)	2000-10-20	2000-10-20	Astrazeneca Ab	Novel compounds
HUP0500880A2 (en) *	2000-12-11	2006-05-29	Tularik Inc	Cxcr3 antagonists and pharmaceutical compositions thereof
SE0101322D0 (sv)	2001-04-12	2001-04-12	Astrazeneca Ab	Novel compounds
US6794379B2 (en)	2001-06-06	2004-09-21	Tularik Inc.	CXCR3 antagonists
SE0102716D0 (sv) *	2001-08-14	2001-08-14	Astrazeneca Ab	Novel compounds
GB0221829D0 (en) *	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
GB0221828D0 (en) *	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
US7067658B2 (en)	2002-09-30	2006-06-27	Bristol-Myers Squibb Company	Pyridino and pyrimidino pyrazinones
US6861422B2 (en)	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
GB0328243D0 (en) *	2003-12-05	2004-01-07	Astrazeneca Ab	Methods
US7271271B2 (en)	2004-06-28	2007-09-18	Amgen Sf, Llc	Imidazolo-related compounds, compositions and methods for their use
US7375102B2 (en)	2004-06-28	2008-05-20	Amgen Sf, Llc	Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
US7939538B2 (en)	2004-06-28	2011-05-10	Amgen Inc.	Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
DE102004033670A1 (de)	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060074088A1 (en)	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) *	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
US20060035903A1 (en)	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US7759485B2 (en)	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US7728134B2 (en)	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
DE102004058337A1 (de)	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
CA2590294A1 (en) *	2004-12-13	2006-06-22	Sunesis Pharmaceuticals, Inc.	Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
AR053347A1 (es)	2005-04-06	2007-05-02	Astrazeneca Ab	Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos
UA90707C2 (en)	2005-04-06	2010-05-25	Астразенека Аб	Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
US7439358B2 (en)	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP3098223A1 (en)	2007-08-03	2016-11-30	Boehringer Ingelheim International GmbH	Crystalline form of a dihydropteridione derivative
JP2011528030A (ja) *	2008-07-16	2011-11-10	アストラゼネカ・アクチエボラーグ	ピリミジルスルホンアミド誘導体およびケモカイン介在疾患処置のためのその使用
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
US9359361B2 (en) *	2011-06-01	2016-06-07	Janus Biotherapeutics, Inc.	Immune system modulators
WO2014205127A2 (en)	2013-06-18	2014-12-24	New York University	Cellular factors involved in the cytotoxicity of staphylococcus aureus leukocidins: novel therapeutic targets
EP3024464A1 (en)	2013-07-26	2016-06-01	Boehringer Ingelheim International GmbH	Treatment of myelodysplastic syndrome
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2924472A (en)	1957-06-27	1960-02-09	Gen Motors Corp	Pipe joint seal
GB1009477A (en)	1962-02-13	1965-11-10	Smith Kline French Lab	Novel process for preparing heterocyclic compounds
US3318900A (en)	1964-05-06	1967-05-09	Janssen Pharmaceutica Nv	Derivatives of benzimidazolinyl piperidine
BE668603A (pt)	1964-08-20
US3859287A (en) *	1971-05-05	1975-01-07	Walter Wesley Parish	Thiopteridines and process for producing same
DE2331223C2 (de)	1972-06-19	1984-11-22	Kohjin Co., Ltd., Tokio / Tokyo	S-substituierte-2-Thioadenosine, deren 5'-Monophosphate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
US4120521A (en)	1975-08-28	1978-10-17	Rieber & Son Plastic-Industri A/S	Combined mould element and sealing ring
EG12406A (en)	1976-08-12	1979-03-31	Janssen Pharmaceutica Nv	Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GB1600293A (en)	1977-02-04	1981-10-14	British Oceanics Ltd	Sealing arrangements
US4188040A (en)	1977-04-06	1980-02-12	Firma WOCO Franz-Josef Wolf & Co.	Sealing ring
DE2726959A1 (de)	1977-06-15	1979-01-18	Arlt Christian	Dichteinsatz zum dichten verbinden von zwei rohren
FR2421899A1 (fr)	1978-01-16	1979-11-02	Roussel Uclaf	Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
US4410528A (en)	1980-05-16	1983-10-18	Kyowa Hakko Kogyo Co., Ltd.	Hypotensive piperidine derivatives
DE3219522A1 (de)	1981-10-28	1983-12-01	Denso-Chemie Wedekind Kg, 5090 Leverkusen	Steckmuffendichtung fuer rohre
FR2547888B1 (fr)	1983-06-22	1985-12-13	Sabla Sa	Bague d'etancheite a implants pour tuyaux a emboitement
HU195822B (en) *	1985-12-30	1988-07-28	Gyogyszerkutato Intezet	Process for producing new pyrimido/5,4-b//1,h/oxazine derivatives
CA1338012C (en) *	1987-04-27	1996-01-30	John Michael Mccall	Pharmaceutically active amines
SE8800348L (sv)	1988-02-03	1989-08-04	Forsheda Ab	Taetningsring och verktyg foer framstaellning daerav
FR2659656B1 (fr) *	1990-03-15	1994-09-09	Sanofi Sa	Derives de pyrimidinedione-2,4 et medicaments les contenant.
DE4119767A1 (de)	1991-06-15	1992-12-17	Dresden Arzneimittel	Verfahren zur herstellung von (pyrimid-2-yl-thio- bzw. seleno)-essigsaeurederivaten
JP3100469B2 (ja) *	1991-07-03	2000-10-16	中外製薬株式会社	乾癬治療剤
US5169161A (en)	1991-09-19	1992-12-08	Hail Mary Rubber Co., Inc.	Symmetrical gasket for pipe joints
DE4134089C2 (de)	1991-10-15	1994-10-13	Dueker Eisenwerk	Schubgesicherte Muffenverbindung
JPH05188994A (ja)	1992-01-07	1993-07-30	Sony Corp	騒音抑圧装置
DE4229609C2 (de)	1992-09-04	2003-05-08	Forsheda Stefa Gmbh	Abdichtung zwischen zwei ineinandersteckbaren Teilen
US5521197A (en)	1994-12-01	1996-05-28	Eli Lilly And Company	3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
PT778277E (pt)	1995-12-08	2003-11-28	Pfizer	Derivados heterociclicos substituidos como antagonistas do crf
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
SE515033C2 (sv)	1995-12-27	2001-06-05	Forsheda Ab	Tätningsanordning
KR19990082463A (ko)	1996-02-13	1999-11-25	돈 리사 로얄	혈관 내피 성장 인자 억제제로서의 퀴나졸린유도체
ATE211134T1 (de)	1996-03-05	2002-01-15		4-anilinochinazolin derivate
WO1997040035A1 (en)	1996-04-19	1997-10-30	Neurosearch A/S	1-(4-piperidyl)-benzimidazoles having neurotrophic activity
AU735401B2 (en)	1996-08-28	2001-07-05	Pfizer Inc.	Substituted 6,5-hetero-bicyclic derivatives
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
AU5522498A (en)	1996-12-13	1998-07-03	Merck & Co., Inc.	Substituted aryl piperazines as modulators of chemokine receptor activity
GB9714249D0 (en)	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
AU8576098A (en)	1997-07-25	1999-02-16	Merck & Co., Inc.	Cyclic amine modulators of chemokine receptor activity
AR013669A1 (es)	1997-10-07	2001-01-10	Smithkline Beecham Corp	Compuestos y metodos
KR100613634B1 (ko)	1997-11-28	2006-08-18	다이닛본 스미토모 세이야꾸 가부시끼가이샤	신규한 복소환 화합물
TR200002090T2 (tr)	1998-01-19	2000-11-21	Pfizer Inc.	Orl1-alıcı agonistleri olan 4-(2-keto-1-benzimidazolinil)piperidin bileşikleri
CA2324550A1 (en)	1998-03-19	1999-09-23	Shigeyuki Chaki	Arylpiperidine derivatives and use thereof
WO1999051608A1 (en)	1998-04-03	1999-10-14	Du Pont Pharmaceuticals Company	THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
MA26659A1 (fr)	1998-08-06	2004-12-20	Pfizer	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9802729D0 (sv)	1998-08-13	1998-08-13	Astra Pharma Prod	Novel Compounds
US5988695A (en)	1998-08-26	1999-11-23	S&B Technical Products, Inc.	Pipe gasket with embedded ring
PE20001420A1 (es)	1998-12-23	2000-12-18	Pfizer	Moduladores de ccr5
JP2002533464A (ja)	1998-12-28	2002-10-08	カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント	プテリジン誘導体の免疫抑制作用
GB9900334D0 (en)	1999-01-07	1999-02-24	Angiogene Pharm Ltd	Tricylic vascular damaging agents
GB9900752D0 (en)	1999-01-15	1999-03-03	Angiogene Pharm Ltd	Benzimidazole vascular damaging agents
EP1187615A2 (en)	1999-02-02	2002-03-20	K.U. Leuven Research & Development	Immunosurpressive effects of pteridine derivatives
US6248755B1 (en)	1999-04-06	2001-06-19	Merck & Co., Inc.	Pyrrolidine modulators of chemokine receptor activity
US6142484A (en)	1999-04-15	2000-11-07	Vassallo Research & Development Corporation	Composite multi-pressure gasket
US6432981B1 (en)	1999-06-11	2002-08-13	Merck & Co., Inc.	Cyclopentyl modulators of chemokine receptor activity
US6340681B1 (en)	1999-07-16	2002-01-22	Pfizer Inc	2-benzimidazolylamine compounds as ORL-1-receptor agonists
BR0013952A (pt)	1999-09-15	2002-05-14	Warner Lambert Co	Pteridinonas como inibidores de cinase
PE20010628A1 (es)	1999-10-01	2001-06-18	Takeda Chemical Industries Ltd	Compuestos de amina ciclica, su produccion y su uso
SE9903544D0 (sv)	1999-10-01	1999-10-01	Astra Pharma Prod	Novel compounds
EP1122257B1 (en)	2000-01-05	2005-10-12	Pfizer Inc.	Benzimidazole compounds as ORL1-receptor agonists
GB2359078A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
EP1257555B1 (en)	2000-02-11	2003-12-03	AstraZeneca AB	Pyrimidine compounds and their use as modulators of chemokine receptor activity
GB2359079A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB2359081A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active thiazolopyrimidines
GB2359551A (en)	2000-02-23	2001-08-29	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en)	2000-03-10	2000-05-03	Astrazeneca Uk Ltd	Chemical compounds
CA2404280A1 (en)	2000-03-24	2002-09-23	Meiji Seika Kaisha, Ltd.	Diphenylalkylamine derivatives useful as opioid .delta. receptor agonists
BR0111230A (pt)	2000-05-31	2003-06-10	Astrazeneca Ab	Composto, e, uso e processo para a preparação do mesmo
EE200300015A (et)	2000-07-07	2004-10-15	Angiogene Pharmaceuticals Limited	Kolhinooli derivaadid kui angiogeneesi inhibiitorid
MXPA02012905A (es)	2000-07-07	2004-07-30	Angiogene Pharm Ltd	Derivados de colquinol como agentes de dano vascular..
SE0003828D0 (sv)	2000-10-20	2000-10-20	Astrazeneca Ab	Novel compounds
SE0004110L (sv)	2000-11-10	2002-05-11	Forsheda Ab	Tätningsring
SE0101322D0 (sv)	2001-04-12	2001-04-12	Astrazeneca Ab	Novel compounds
SE0102716D0 (sv)	2001-08-14	2001-08-14	Astrazeneca Ab	Novel compounds
GB0221829D0 (en)	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
GB0221828D0 (en)	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
US20070142386A1 (en)	2003-10-07	2007-06-21	Astrazeneca	New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
GB0328243D0 (en)	2003-12-05	2004-01-07	Astrazeneca Ab	Methods
WO2005082865A1 (ja)	2004-02-27	2005-09-09	Astellas Pharma Inc.	縮合二環性ピリミジン誘導体
JP2008524186A (ja)	2004-12-17	2008-07-10	アストラゼネカ・アクチエボラーグ	ケモカイン受容体活性の調節のためのチアゾロピラミジン化合物

2000
- 2000-02-23 GB GB0004128A patent/GB2359551A/en not_active Withdrawn
2001
- 2001-02-20 MX MXPA02008233A patent/MXPA02008233A/es active IP Right Grant
- 2001-02-20 BR BR0108600-6A patent/BR0108600A/pt not_active Application Discontinuation
- 2001-02-20 EE EEP200200461A patent/EE200200461A/xx unknown
- 2001-02-20 CN CNB018054676A patent/CN1190437C/zh not_active Expired - Fee Related
- 2001-02-20 UA UA2002097583A patent/UA72590C2/uk unknown
- 2001-02-20 CA CA002400217A patent/CA2400217C/en not_active Expired - Fee Related
- 2001-02-20 HU HU0204399A patent/HUP0204399A3/hu unknown
- 2001-02-20 JP JP2001562540A patent/JP2003524012A/ja active Pending
- 2001-02-20 AU AU34316/01A patent/AU782509B2/en not_active Ceased
- 2001-02-20 CZ CZ20022839A patent/CZ20022839A3/cs unknown
- 2001-02-20 US US10/204,814 patent/US6875868B2/en not_active Expired - Fee Related
- 2001-02-20 AT AT01906493T patent/ATE250605T1/de active
- 2001-02-20 DE DE60100851T patent/DE60100851T2/de not_active Expired - Lifetime
- 2001-02-20 KR KR1020027011047A patent/KR100795758B1/ko not_active IP Right Cessation
- 2001-02-20 IL IL15113201A patent/IL151132A0/xx unknown
- 2001-02-20 RU RU2002125451/04A patent/RU2002125451A/ru not_active Application Discontinuation
- 2001-02-20 EP EP01906493A patent/EP1259512B1/en not_active Expired - Lifetime
- 2001-02-20 WO PCT/SE2001/000374 patent/WO2001062758A1/en not_active Application Discontinuation
- 2001-02-20 TR TR2003/02214T patent/TR200302214T4/xx unknown
- 2001-02-20 SK SK1215-2002A patent/SK12152002A3/sk unknown
- 2001-02-20 PT PT01906493T patent/PT1259512E/pt unknown
- 2001-02-20 PL PL01358004A patent/PL358004A1/xx not_active Application Discontinuation
- 2001-02-20 DK DK01906493T patent/DK1259512T3/da active
- 2001-02-20 NZ NZ520355A patent/NZ520355A/en not_active IP Right Cessation
- 2001-02-20 ES ES01906493T patent/ES2206402T3/es not_active Expired - Lifetime
- 2001-02-21 CO CO01013781A patent/CO5290258A1/es not_active Application Discontinuation
- 2001-02-21 AR ARP010100773A patent/AR029805A1/es not_active Application Discontinuation
2002
- 2002-08-07 IL IL151132A patent/IL151132A/en not_active IP Right Cessation
- 2002-08-07 IS IS6491A patent/IS6491A/is unknown
- 2002-08-14 BG BG107002A patent/BG107002A/bg unknown
- 2002-08-16 ZA ZA200206590A patent/ZA200206590B/en unknown
- 2002-08-22 NO NO20024005A patent/NO329898B1/no not_active IP Right Cessation
2003
- 2003-05-02 HK HK03103155A patent/HK1050899A1/xx not_active IP Right Cessation
2004
- 2004-07-15 US US10/891,833 patent/US7579342B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU782509B2 (en)	2005-08-04
PL358004A1 (en)	2004-08-09
DK1259512T3 (da)	2003-12-29
NZ520355A (en)	2005-01-28
US20030055250A1 (en)	2003-03-20
NO20024005D0 (no)	2002-08-22
UA72590C2 (uk)	2005-03-15
NO20024005L (no)	2002-10-22
CN1190437C (zh)	2005-02-23
SK12152002A3 (sk)	2003-03-04
KR100795758B1 (ko)	2008-01-21
MXPA02008233A (es)	2004-04-05
TR200302214T4 (tr)	2004-01-21
DE60100851D1 (de)	2003-10-30
EE200200461A (et)	2003-12-15
HUP0204399A2 (en)	2003-05-28
AU3431601A (en)	2001-09-03
BR0108600A (pt)	2002-11-12
GB0004128D0 (en)	2000-04-12
GB2359551A (en)	2001-08-29
IS6491A (is)	2002-08-07
CA2400217A1 (en)	2001-08-30
WO2001062758A1 (en)	2001-08-30
EP1259512B1 (en)	2003-09-24
EP1259512A1 (en)	2002-11-27
US6875868B2 (en)	2005-04-05
KR20030005207A (ko)	2003-01-17
US7579342B2 (en)	2009-08-25
CA2400217C (en)	2009-02-17
HUP0204399A3 (en)	2004-11-29
HK1050899A1 (en)	2003-07-11
IL151132A0 (en)	2003-04-10
CZ20022839A3 (cs)	2002-11-13
ATE250605T1 (de)	2003-10-15
IL151132A (en)	2010-11-30
RU2002125451A (ru)	2004-01-10
US20050171345A1 (en)	2005-08-04
JP2003524012A (ja)	2003-08-12
CN1404482A (zh)	2003-03-19
NO329898B1 (no)	2011-01-24
CO5290258A1 (es)	2003-06-27
ES2206402T3 (es)	2004-05-16
DE60100851T2 (de)	2004-07-15
PT1259512E (pt)	2004-02-27
AR029805A1 (es)	2003-07-16
ZA200206590B (en)	2003-11-17

Publication	Publication Date	Title
BG107002A (bg)	2003-04-30	Птеридинови съединения за лечение на псориазис
JP4824889B2 (ja)	2011-11-30	新規チアゾロ（４，５−ｄ）ピリミジン化合物
US6806273B1 (en)	2004-10-19	Compounds
IL150952A (en)	2010-11-30	Preparation of dosage forms of clear aqueous solution with bile acids
US20070142352A1 (en)	2007-06-21	Pteridinone Derivatives as Modulators of Chemokine Receptor Activity
JP4250416B2 (ja)	2009-04-08	ケモカイン関連疾患の処置のための７−アミノ−２−アルキルチオプテリジン−４−イルアミン
US6958344B2 (en)	2005-10-25	Pyrimidine compounds and their use as modulators of chemokine receptor activity
JP2003522189A5 (pt)	2008-03-27
EP1385854B1 (en)	2005-02-09	Thiazolopyrimidines and their use as modulators of chemokine receptor activity